Valion Bio
VBIO
9 hedge funds and large institutions have $233K invested in Valion Bio in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
97% more capital invested
Capital invested by funds: $119K → $233K (+$115K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
29% more funds holding
Funds holding: 7 → 9 (+2)
5.82% more ownership
Funds ownership: 4.64% → 10.46% (+5.8%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$89.9K |
| 2 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
+$62.6K |
| 3 |
HF
HRT Financial
New York
|
+$43.4K |
| 4 |
MG
Marex Group
London,
|
+$18.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$17.7K |
| 3 |
Citigroup
New York
|
-$7.25K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.09K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$19 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $77.8K | +$89.9K | +87,818 | New |
|
|
SA
2
Sanctuary Advisors
Indianapolis,
Indiana
| $54.2K | +$62.6K | +61,205 | New |
|
|
MG
3
Marex Group
London,
| $52.5K | +$18.7K | +18,321 | +45% |
|
|
HF
4
HRT Financial
New York
| $37K | +$43.4K | +42,419 | New |
|
|
XT
5
XTX Topco
George Town,
Cayman Islands
| $9.31K | +$10.8K | +10,506 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $2.1K | -$17.7K | -17,293 | -88% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $517 | -$1.09K | -1,064 | -65% |
|
|
SS
8
SBI Securities
Tokyo,
Japan
| $14 | – | – | – |
|
|
CIAM
9
Caitong International Asset Management
Hong Kong
| $1 | +$1 | +1 | New |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$21.2K | -14,639 | Closed |
|
|
11
Citigroup
New York
| – | -$7.25K | -4,998 | Closed |
|
|
12
Bank of America
Charlotte,
North Carolina
| – | -$19 | -13 | Closed |
|
VBIO Hedge Fund Activity: Q1 2026 in Review
9 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q1 2026, worth a combined $233K — up 97% from $119K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new VBIO positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $89.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $21.2K sold.
- 9 institutional investors held Valion Bio (VBIO) as of Q1 2026, up from 7 in Q4 2025.
- Funds reported $233K of Valion Bio stock for Q1 2026, up 97% quarter-over-quarter.
- 5 funds opened new Valion Bio positions in Q1 2026 and 3 closed out, a net change of +2 holders.
- The largest Valion Bio buyer in Q1 2026 was Geode Capital Management, an estimated $89.9K added.
- The largest Valion Bio seller in Q1 2026 was Susquehanna International Group, an estimated $21.2K sold.
Based on aggregated 13F filings for Q1 2026.